Skip to main content
OpenTrials
Completed

NCT Number: NCT03291730

A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting

The investigators are conducting a project to provide a new type of resource called "hand lettering" to patients receiving chemotherapy. This is a type of art therapy. The goal of this project is to understand if it is feasible to use art-therapy and to describe anxiety before and after completing hand-lettering.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anxiety Anxiety Disorders Mental Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dana Farber Cancer Institute

Boston, Massachusetts, 02115, United States

About this study

This study is being done to understand if it is feasible to use a form of art-therapy called hand-lettering at Dana-Farber Cancer Institute. We would also like to explore the anxiety a person has before and after using hand-lettering.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (>age 18) with a cancer diagnosis receiving oral or IV chemotherapy at Dana-Farber on Yawkey 10.
  • Able to read and speak English
  • Has a minimum appointment time of 60 minutes

Exclusion criteria

-Individuals with visual impairment or blindness will be excluded

Treatment and study plan

Breathing and journaling exercise

Behavioral

May help reduce anxiety of receiving chemotherapy

Art-therapy

Other

May help reduce anxiety of receiving chemotherapy

Primary outcomes

  1. Evaluate the feasibility of implementing nurse-led hand-lettering in an ambulatory infusion setting

    Time frame: 2 years

    Feasibility will be defined through enrollment and completion rates.

Secondary outcomes

  1. Describe patient self-reported anxiety before and after utilizing hand-lettering

    Time frame: 2 years

    Anxiety measured through the State Trait Anxiety Index.

Sponsors and collaborators

Lead sponsor

Dana-Farber Cancer Institute

Other

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Sep 25, 2017
Registry last updated
Dec 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.